Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jul 15:183:89-100.
doi: 10.1016/j.actbio.2024.05.020. Epub 2024 May 25.

Effects of amyloid-β-mimicking peptide hydrogel matrix on neuronal progenitor cell phenotype

Affiliations

Effects of amyloid-β-mimicking peptide hydrogel matrix on neuronal progenitor cell phenotype

Tess Grett Mathes et al. Acta Biomater. .

Abstract

Self-assembling peptide-based hydrogels have become a highly attractive scaffold for three-dimensional (3D) in vitro disease modeling as they provide a way to create tunable matrices that can resemble the extracellular matrix (ECM) of various microenvironments. Alzheimer's disease (AD) is an exceptionally complex neurodegenerative condition; however, our understanding has advanced due to the transition from two-dimensional (2D) to 3D in vitro modeling. Nonetheless, there is a current gap in knowledge regarding the role of amyloid structures, and previously developed models found long-term difficulty in creating an appropriate model involving the ECM and amyloid aggregates. In this report, we propose a multi-component self-assembling peptide-based hydrogel scaffold to mimic the amyloid-beta (β) containing microenvironment. Characterization of the amyloid-β-mimicking hydrogel (Col-HAMA-FF) reveals the formation of β-sheet structures as a result of the self-assembling properties of phenylalanine (Phe, F) through π-π stacking of the residues, thus mimicking the amyloid-β protein nanostructures. We investigated the effect of the amyloid-β-mimicking microenvironment on healthy neuronal progenitor cells (NPCs) compared to a natural-mimicking matrix (Col-HAMA). Our results demonstrated higher levels of neuroinflammation and apoptosis markers when NPCs were cultured in the amyloid-like matrix compared to a natural brain matrix. Here, we provided insights into the impact of amyloid-like structures on NPC phenotypes and behaviors. This foundational work, before progressing to more complex plaque models, provides a promising scaffold for future investigations on AD mechanisms and drug testing. STATEMENT OF SIGNIFICANCE: In this study, we engineered two multi-component hydrogels: one to mimic the natural extracellular matrix (ECM) of the brain and one to resemble an amyloid-like microenvironment using a self-assembling peptide hydrogel. The self-assembling peptide mimics β-amyloid fibrils seen in amyloid-β protein aggregates. We report on the culture of neuronal progenitor cells within the amyloid-mimicking ECM scaffold to study the impact through marker expressions related to inflammation and DNA damage. This foundational work, before progressing to more complex plaque models, offers a promising scaffold for future investigations on AD mechanisms and drug testing.

Keywords: Alzheimer's disease; Amyloid fibrils; Hydrogel; Neuronal cells; Peptide self-assembly.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Figure 1.
Figure 1.. Scheme of the overall project.
Scheme showing the construction of a “healthy” (left) and an “amyloid” (right) state hydrogel matrix and the expression of certain neuronal markers when cultured in each one. Scale bar 50 μm.
Figure 2.
Figure 2.. Rheological characterization of Col-HAMA and Col-HAMA-FF hydrogels.
A. Scheme showing components of hydrogel matrix. B. Frequency sweep at 1% strain. C. amplitude sweep. D. temperature sweep from 10–50°C. E. step strain sweeps showing the storage (purple) and loss (blue) modulus of Col-HAMA and the storage (green) and loss (orange) modulus of Col-HAMA-FF hydrogels in repeating cycles from 1 to 200%. F. Viscosity of Col-HAMA (purple) and Col-HAMA-FF hydrogel.
Figure 3.
Figure 3.. ThT and β-sheet characterization in Col-HAMA and Col-HAMA-FF hydrogels.
A. Scheme showing when ThT binds to amyloid aggregates, it gives rise to fluorescent signals. B. ThT tests on our hydrogel components alone and its various mixtures show the formation of aggregates in the Col-HAMA-FF hydrogels through fluorescent intensity (FI). C. FT-IR studies showing the formation of β-sheet functional groups.
Figure 4.
Figure 4.. In vitro cytotoxicity effects.
A. Live/dead studies of HDF cells with both hydrogel matrices Scale bars: 200 μm. B. Quantification of live/dead cells. C. Presto Blue study to show cell proliferation after indirect contact with gels. D. Live/dead studies of NPCs cultured in various matrices. (Scale bars: 100 μm; n = 3) (Two-way Anova, Tukey’s post hoc test *p < 0.05, **p < 0.01, ***p < 0.005, ****p<0.001).
Figure 5.
Figure 5.. Pax-6 and Nestin staining of NPCs cultured in healthy versus amyloid hydrogel matrices.
A. Microscopy images. B. Pax-6 quantification (control, CH, n=5, CHFF, n=6). C. Nestin quantification (n=6). Scale bar = 50 μm. (One-way Anova, Tukey’s post hoc test *p < 0.05, **p < 0.01, ***p < 0.005, ****p<0.001).
Figure 6.
Figure 6.. β-tubulin and TNF-α staining of NPCs cultured in both hydrogel states.
A. Microscopy images. B. β-tubulin quantification (n=5). C. TNF-α quantification (n=5). Scale bar = 50 μm.; (One-way Anova, Tukey’s post hoc test p < 0.05, p < 0.01, p < 0.005, **** p<0.001).
Figure 7.
Figure 7.. Ki-67 and PARP staining of NPCs cultured in both hydrogel states.
A. Microscopy images. B. Ki-67 quantification (control, CHFF n=5, CH, n=6). C. PARP quantification (control, CH, n=6, CHFF, n=5). Scale bar = 50 μm. (One-way Anova, Tukey’s post hoc test *p < 0.05, **p < 0.01, ***p < 0.005, ****p<0.001).

Similar articles

Cited by

References

    1. Jicha GA, Carr SA, Conceptual evolution in Alzheimer's disease: implications for understanding the clinical phenotype of progressive neurodegenerative disease, Journal of Alzheimer's Disease 19(1) (2010) 253–272. - PMC - PubMed
    1. Walsh DM, Selkoe DJ, Amyloid β-protein and beyond: The path forward in Alzheimer’s disease, Current opinion in neurobiology 61 (2020) 116–124. - PubMed
    1. Ashrafian H, Zadeh EH, Khan RH, Review on Alzheimer's disease: inhibition of amyloid beta and tau tangle formation, International journal of biological macromolecules 167 (2021) 382–394. - PubMed
    1. Ávila-Villanueva M, Marcos Dolado A, Gómez-Ramírez J, Fernández-Blázquez M, Brain structural and functional changes in cognitive impairment due to Alzheimer’s disease, Frontiers in psychology 13 (2022) 886619. - PMC - PubMed
    1. Gulisano W, Maugeri D, Baltrons MA, Fà M, Amato A, Palmeri A, D'Adamio L, Grassi C, Devanand D, Honig LS, Role of Amyloid-β and Tau Proteins in Alzheimer's Disease: Confuting the Amyloid Cascade, Journal of Alzheimer's Disease: JAD 68(1) (2019) 415–415. - PubMed

Publication types

LinkOut - more resources